- Home
- RLAY vs LXU Comparison
RLAY vs LXU Comparison
Compare RLAY & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- LXU
- Stock Information
- Founded
- RLAY 2015
- LXU 1968
- Country
- RLAY United States
- LXU United States
- Employees
- RLAY N/A
- LXU N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- LXU Major Chemicals
- Sector
- RLAY Health Care
- LXU Industrials
- Exchange
- RLAY Nasdaq
- LXU Nasdaq
- Market Cap
- RLAY 610.3M
- LXU 612.4M
- IPO Year
- RLAY 2020
- LXU 1969
- Fundamental
- Price
- RLAY $3.54
- LXU $7.65
- Analyst Decision
- RLAY Strong Buy
- LXU Buy
- Analyst Count
- RLAY 12
- LXU 3
- Target Price
- RLAY $18.45
- LXU $10.08
- AVG Volume (30 Days)
- RLAY 2.8M
- LXU 494.9K
- Earning Date
- RLAY 08-07-2025
- LXU 07-29-2025
- Dividend Yield
- RLAY N/A
- LXU N/A
- EPS Growth
- RLAY N/A
- LXU N/A
- EPS
- RLAY N/A
- LXU N/A
- Revenue
- RLAY $8,355,000.00
- LXU $538,851,000.00
- Revenue This Year
- RLAY $17.59
- LXU $11.05
- Revenue Next Year
- RLAY N/A
- LXU $1.97
- P/E Ratio
- RLAY N/A
- LXU N/A
- Revenue Growth
- RLAY N/A
- LXU 2.60
- 52 Week Low
- RLAY $1.78
- LXU $4.88
- 52 Week High
- RLAY $10.72
- LXU $9.68
- Technical
- Relative Strength Index (RSI)
- RLAY 52.25
- LXU 45.18
- Support Level
- RLAY $3.31
- LXU $7.15
- Resistance Level
- RLAY $3.61
- LXU $7.77
- Average True Range (ATR)
- RLAY 0.21
- LXU 0.36
- MACD
- RLAY -0.02
- LXU -0.03
- Stochastic Oscillator
- RLAY 68.67
- LXU 34.57
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.